The Europe Protein Crystallization Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).
The creation of new technology significantly impacts the need for protein crystallization. Moreover, the market for crystallization and crystallography will expand due to the growing demand for high-resolution data on protein structures. Increased government funding and R&D efforts in the pharmaceutical and biotechnology sectors, which necessitate the use of crystallization and crystallography methods, are further factors driving the growth of the protein crystallization market.
One of the main factors fueling the market's expansion is the rising need for protein therapies. This is due to protein therapies' recent integration into the healthcare sector. In addition, because of their low immunogenicity and specificity, protein therapies are widely employed to treat various severe disorders, including cancer. As a result, the manufacturers have adopted growth strategies to capture the largest market share, consequently accelerating the market's growth, in response to the rising demand for protein-based medications and treatments.
Pharmaceutical companies have been driven to provide effective medications to combat the growing number of cardiac problems due to the expanding disease burden prevalence. The governments in the area are also establishing regulations that will facilitate the production and approval of various pharmaceuticals. In 2018, Russia spent an average of $140 per person on prescription drugs. Pharmaceutical sales in Russia were over $20.1 billion in the same year, accounting for 1.2% of the country's GDP and 22.1% of its total health expenditures. The market for protein crystallization is expected to grow in Europe due to the rising healthcare and pharmaceutical industries there.
The Germany market dominated the Europe Protein Crystallization Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $117.6 million by 2028. The UK market is anticipated to grow at a CAGR of 6.8% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 8.6% during (2022 - 2028).
Based on End User, the market is segmented into Pharmaceutical & BioProduct Companies and Academic & Research Institutes. Based on Technology, the market is segmented into X-ray Crystallography, Cryo-electron Microscopy, NMR Spectroscopy and Others. Based on Product, the market is segmented into Instruments, Consumables and Software & Services. Based on Instruments Type, the market is segmented into Liquid Handling Instruments and Crystal Imaging Instruments. Based on Consumables Type, the market is segmented into Reagents & Kits/Screens, Micro Plates and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Protein Crystallization Market will Hit $1.8 Billion by 2028, at a CAGR of 8.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bruker Corporation, Corning Incorporated, Mettler-Toledo International, Inc., Greiner Bio-One International GmbH (Greiner AG), Rigaku Holdings Corporation, Formulatrix, Inc., Hampton Research Corp., Jena Bioscience GmbH, Creative Proteomics, and Molecular Dimentions Ltd (Anatrace Products LLC)
By End User
By Technology
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 